TherapeuticsMD, Inc

(NASDAQ:TXMD)

Latest On TherapeuticsMD, Inc (TXMD):

Date/Time Type Description Signal Details
2023-05-23 18:47 ESTNewsTherapeuticsMD: From Fallen And Forgotten To Cash CowN/A
2023-05-16 05:29 ESTNewsTherapeutics MD GAAP EPS of -$0.24 beats by $0.87N/A
2023-04-10 13:04 ESTNewsTherapeutics MD GAAP EPS of -$0.12N/A
2023-01-19 00:02 ESTNewsTherapeuticsMD ends agreement with interim CFO, but will stay on in consulting roleN/A
2022-12-05 15:42 ESTNewsTherapeuticsMD enters agreements to license products to Mayne PharmaN/A
2022-11-18 04:18 ESTNewsTherapeuticsMD: Challenged Women's Health Company Needs A SaviorN/A
2022-11-15 09:08 ESTNewsTherapeutics MD GAAP EPS of -$3.13 misses by $1.09, revenue of $20.92M misses by $9.28MN/A
2022-10-31 08:22 ESTNewsTherapeuticsMD raises additional $7M in private investmentN/A
2022-10-03 17:28 ESTNewsTherapeuticsMD raises $7M in private placementN/A
2022-09-13 01:15 ESTNewsTherapeuticsMD appoints interim co-CEOsN/A
2022-08-18 01:46 ESTNewsTherapeuticsMD: Looking To Annovera To Save The DayN/A
2022-08-17 08:16 ESTNewsTherapeuticsMD, Inc.'s (TXMD) CEO Hugh O'Dowd on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-15 22:56 ESTNewsTherapeutics MD GAAP EPS of $12.39, revenue of $28.6MN/A
2022-08-15 22:56 ESTNewsTherapeuticsMD, Inc. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-15 22:56 ESTNewsTherapeuticsMD, Inc. (TXMD) CEO Hugh O'Dowd on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-15 22:56 ESTNewsTherapeuticsMD rises 22% on strong Q2 result as Annovera sales riseN/A
2022-08-13 02:21 ESTNewsTherapeutics MD Q2 Earnings PreviewN/A
2022-08-01 16:58 ESTNewsTherapeuticsMD receives $15M equity investment from Rubric CapitalN/A
2022-07-19 23:26 ESTNewsTherapeuticsMD jumps 12% as top investor discloses insider purchaseN/A
2022-07-13 22:22 ESTNewsTherapeuticsMD plunges 42% as merger agreement endsN/A
2022-07-06 12:12 ESTNewsTherapeuticsMD risks bankruptcy as EW Healthcare extends tender offer for acquisitionN/A
2022-06-17 02:48 ESTNewsTherapeuticsMD: Privatization Deal Expected To Meet With Shareholder PushbackN/A
2022-06-07 19:01 ESTNewsTherapeuticsMD cut to neutral at H.C. Wainwright on private equity acquisitionN/A
2022-06-07 03:23 ESTNewsInovio Pharma, Bionano Genomics among health care stocks to join Russell Microcap Index; Tonix Pharma, iBio to leaveN/A
2022-05-31 12:56 ESTNewsTherapeuticsMD agrees to be acquired by EW Healthcare PartnersN/A
2022-05-21 20:10 ESTNewsTherapeuticsMD surges 25% on sNDA approval for Annovera birth control ringN/A
2022-05-16 20:49 ESTNewsTherapeutics MD GAAP EPS of -$5.69 misses by $1.69, revenue of $19.34M beats by $1.39MN/A
2022-05-16 20:49 ESTNewsTherapeuticsMD quarterly net loss widens 24% on bottom line missN/A
2022-05-16 20:48 ESTNewsTherapeuticsMD, Inc. (TXMD) CEO Hugh O'Dowd on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-16 03:25 ESTNewsTherapeutics MD Q1 2022 Earnings PreviewN/A
2022-05-09 18:10 ESTNewsTherapeuticsMD plunges as reverse stock split takes effectN/A
2022-03-19 09:25 ESTNewsTherapeuticsMD CFO departing company on April 1N/A
2022-03-14 17:57 ESTNewsTherapeuticsMD: Looking For A Potential Turnaround After Divesting VitaCare BusinessN/A
2022-03-11 19:06 ESTNewsTherapeuticsMD, Inc. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-03-11 19:06 ESTNewsTherapeuticsMD price target lowered at H.C. Wainwright on supply constraintsN/A
2022-03-10 23:15 ESTNewsTherapeutics MD GAAP EPS of -$0.10 misses by $0.02, revenue of $18.67M misses by $10.72MN/A
2022-03-10 23:14 ESTNewsTherapeuticsMD slips after Q4 earnings missN/A
2022-03-10 23:14 ESTNewsTherapeuticsMD, Inc. (TXMD) CEO Hugh O'Dowd On Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-09 14:04 ESTNewsTherapeutics MD Q4 2021 Earnings PreviewN/A
2022-03-07 09:55 ESTNewsGoodRx to acquire TherapeuticsMD's vitaCare unit for $150MN/A
2022-01-04 03:46 ESTNewsTherapeuticsMD rebounds after announcing FDA approval for low dose BIJUVAN/A
2021-12-10 23:52 ESTNewsTherapeuticsMD says FDA rejected production updates for birth control ringN/A
2021-12-08 14:40 ESTNewsTherapeuticsMD settles U.S. patent litigation with Amneal for BijuvaN/A
2021-11-11 14:43 ESTNewsTherapeutics MD EPS misses by $0.01, misses on revenueN/A
2021-11-11 14:43 ESTNewsTherapeuticsMD new initiative designed to save $40M in annual costsN/A
2021-11-11 14:43 ESTNewsTherapeuticsMD, Inc. (TXMD) CEO Rob Finizio on Q3 2021 Earnings Conference Call - Earnings Call TranscriptN/A
2021-11-11 14:43 ESTNewsTherapeuticsMD, Inc. 2021 Q3 - Results - Earnings Call PresentationN/A
2021-11-10 17:31 ESTNewsTherapeutics MD Q3 2021 Earnings PreviewN/A
2021-10-22 20:57 ESTNewsTherapeuticsMD: Time For Bulls To Take A Contrarian ApproachN/A
2021-08-10 13:29 ESTNewsTherapeuticsMD names Hugh O’Dowd as presidentN/A

About TherapeuticsMD, Inc (TXMD):

TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; and TX-007HR and TX-008HR, which are transdermal patch product candidates. The company's clinical development product is TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription prenatal vitamin and hormone therapy drug products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

TXMD Quotes by TradingView

See Advanced Chart

General

  • Name TherapeuticsMD, Inc
  • Symbol TXMD
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-Specialty & Generic
  • Full Time Employees 400
  • Last Split Factor1:100
  • Last Split Date2011-10-03
  • Fiscal Year EndDecember
  • IPO Date2003-12-11
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.therapeuticsmd.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 6.8
  • Price/Book (Most Recent Quarter) 40.75
  • Enterprise Value Revenue 12.16
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$0.37
  • Next Year EPS Estimate -$0.11
  • Next Quarter EPS Estimate -$0.10
  • Profit Margin -283%
  • Operating Margin -240%
  • Return on Assets -43%
  • Revenue 64.87 million
  • Earnings Per Share -$0.72
  • Revenue Per Share $0.24
  • Gross Profit 48.9 million
  • Quarterly Earnings Growth 42%
View More

Highlights

  • Market Capitalization 581.74 million
  • EBITDA -151833168
  • PE Ratio -2.12
  • PEG Ratio -0.73
  • Analyst Target Price $6.17
  • Book Value Per Share $0.03
View More

Share Statistics

  • Shares Outstanding 387.83 million
  • Shares Float 361.63 million
  • % Held by Insiders 1122%
  • % Held by Institutions 54.05%
  • Shares Short 55.74 million
  • Shares Short Prior Month 72.67 million
  • Short Ratio 2.59
  • Short % of Float 15%
  • Short % of Shares Outstanding 14%
View More

Technicals

  • Beta 1.98
  • 52 Week High $2.65
  • 52 Week Low $0.85
  • 50 Day Moving Average 1.68
  • 200 Day Moving Average 1.46
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

TherapeuticsMD, Inc (TXMD) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

TherapeuticsMD, Inc (TXMD) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-02$N/A-$0.15-$0.10-44.23%
2020-09-302020-11-09$19.34 million-$0.12-$0.1310.85%
2020-06-302020-08-06$N/A-$0.19-$0.17-10.85%
2020-03-312020-05-06$N/A-$0.21-$0.19-11.41%
2019-12-312020-02-20$15.9 million-$0.19-$0.19-2.54%
2019-09-302019-11-06$23.72 million-$0.13-$0.1931.07%
2019-06-302019-08-06$6.08 million-$0.23-$0.17-34.9%
2019-03-312019-05-06$3.95 million-$0.16-$0.175.77%
2018-12-312019-02-21$5.09 million-$0.17-$0.17-1.43%
2018-09-302018-11-07$3.47 million-$0.16-$0.2225.93%
2018-06-302018-07-30$3.76 million-$0.15-$0.13-12.28%
2018-03-312018-05-03$3.77 million-$0.11-$0.10-8.37%
2017-12-312018-02-20$4.13 million-$0.10-$0.08-18.76%
2017-09-302017-11-06$4.42 million-$0.07-$0.1135.31%
2017-06-302017-08-03$4.25 million-$0.10-$0.102.53%
2017-03-312017-05-02$3.99 million-$0.11-$0.112.22%
2016-12-312017-02-23$4.49 million-$0.12-$0.120%
2016-09-302016-11-03$5.54 million-$0.13-$0.147.14%
2016-06-302016-08-04$4.4 million-$0.11-$0.10-6.49%
2016-03-312016-05-03$4.93 million-$0.11-$0.09-22.22%
2015-12-312016-02-25$5.63 million-$0.10-$0.09-7.18%
2015-09-302015-11-04$5.19 million-$0.11-$0.128.33%
2015-06-302015-08-06$4.85 million-$0.16-$0.11-45.45%
2015-03-312015-05-05$4.48 million-$0.13-$0.10-30%
2014-12-312015-03-10$4.26 million-$0.10-$0.09-11.11%
2014-09-302014-11-06$4.19 million-$0.12-$0.08-50%
2014-06-302014-08-06$3.75 million-$0.07-$0.070%
2014-03-312014-05-05$2.83 million-$0.06-$0.060%
2013-12-312014-03-03$2.86 million-$0.06-$0.05-20%
2013-09-302013-11-04$2.3 million-$0.06-$0.05-20%
2013-06-302013-08-06$2.08 million-$0.05-$0.050%
2013-03-312013-05-08$1.54 million-$0.06-$0.05-20%
2012-12-312013-02-27$1.24 million-$0.06
2012-09-302012-11-28$1.04 million-$0.04
2012-06-302012-06-30$819000-$0.14
2012-03-312012-03-31$722000-$0.16
2011-12-312011-12-31$554000-$0.20
2011-09-302011-09-30$2100-$0.47
2011-06-302011-06-30$508000-$0.34
2011-03-312011-03-31$486000$3.70
2010-12-312010-12-31-$0.66
2010-09-302010-09-30$0.18
2010-06-302010-06-30-$1.69
2010-03-312010-03-31-$2.20
2009-12-312009-12-31-$8.69
2009-09-302009-09-30-$4.21
2009-06-302009-06-30-$0.46
2009-03-312009-03-31-$0.87
2008-12-312008-12-31-$0.46
2008-09-302008-09-30-$1.38
2008-06-302008-06-30-$14.78
2008-03-312008-03-31-$1.98
2007-12-312007-12-31$2.34
2007-09-302007-09-30$0.18
2007-06-302007-06-30$0.18
2007-03-312007-03-31$0.21
2006-12-312006-12-31-$0.12
2006-09-302006-09-30$4.76
2006-06-302006-06-30$0.10
2006-03-312006-03-31$0.15
2005-12-312005-12-31-$0.41
2005-09-302005-09-30$0.95
2005-06-302005-06-30-$2.89
2005-03-312005-03-31$0.80
2004-12-312004-12-31-$0.57
2004-09-302004-09-30-$0.96
2004-06-302004-06-30-$0.08
2004-03-312004-03-31-$2.60
2003-12-312003-12-31-$0.06
2003-09-302003-09-30$0.34
2003-06-302003-06-30$0.02
2003-03-312003-03-31$0.04
2002-12-312002-12-31$0.02
2002-03-312002-03-31$1.38

TherapeuticsMD, Inc (TXMD) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

TherapeuticsMD, Inc (TXMD) Chart:

TherapeuticsMD, Inc (TXMD) News:

Below you will find a list of latest news for TherapeuticsMD, Inc (TXMD) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

TherapeuticsMD, Inc (TXMD) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-1710CALL0 00TRUE00
2024-05-172.50.1CALL0 50FALSE00
2024-05-1750CALL0 00FALSE00
2024-05-177.50CALL0 00FALSE00
2024-05-1710.05PUT0 10FALSE00
2024-05-172.50.05PUT0 1274.79TRUE00
2024-05-1750PUT0 0268.22TRUE00
2024-05-177.50PUT0 0292.47TRUE00
2024-06-2110CALL0 00TRUE00
2024-06-2120.38CALL0 130FALSE00
2024-06-2130.25CALL0 60FALSE00
2024-06-2140.1CALL0 200FALSE00
2024-06-2150CALL0 00FALSE00
2024-06-2160CALL0 00FALSE00
2024-06-2110PUT0 00FALSE00
2024-06-2120.27PUT0 49149.76TRUE00
2024-06-2130.75PUT0 195.01TRUE00
2024-06-2140PUT0 0304.18TRUE00
2024-06-2150PUT0 0218.85TRUE00
2024-06-2160PUT0 0252.07TRUE00
2024-09-2010CALL0 0160.68TRUE00
2024-09-202.50.4CALL0 290FALSE00
2024-09-2050CALL0 00FALSE00
2024-09-207.50CALL0 00FALSE00
2024-09-2010PUT0 00FALSE00
2024-09-202.50.55PUT0 198.87TRUE00
2024-09-2050PUT0 0142.86TRUE00
2024-09-207.50PUT0 0528.31TRUE00
2025-01-1730.29CALL0 190FALSE00
2025-01-1740.19CALL0 881.3FALSE00
2025-01-1750.05CALL0 10FALSE00
2025-01-1770.1CALL0 90FALSE00
2025-01-17100.1CALL0 1090FALSE00
2025-01-17120.1CALL0 20FALSE00
2025-01-17150.2CALL0 120FALSE00
2025-01-1730.85PUT0 386.74TRUE00
2025-01-1741.55PUT0 1114.66TRUE00
2025-01-1751.92PUT0 20187.42TRUE00
2025-01-1774.2PUT0 20181.71TRUE00
2025-01-17100PUT0 0273.87TRUE00
2025-01-17120PUT0 0178.44TRUE00
2025-01-171512.97PUT0 0247.9TRUE00

Latest TXMD Trades:

Date Shares Price
Jun 13, 2022 7:58 PM EST3$9.985
Jun 13, 2022 7:58 PM EST15$9.975
Jun 13, 2022 7:58 PM EST100$9.975
Jun 13, 2022 7:59 PM EST100$9.975
Jun 13, 2022 7:59 PM EST300$9.975

TherapeuticsMD, Inc (TXMD) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000138713120005881/0001387131-20-005881-index.htm
2020-01-21SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/25743/000001961720000126/0000019617-20-000126-index.htm
2019-01-28SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/25743/000003877719000069/0000038777-19-000069-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/25743/000008025519002518/0000080255-19-002518-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/25743/000008025520001136/0000080255-20-001136-index.htm
2019-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/25743/000021545719005746/0000215457-19-005746-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/25743/000031506619001381/0000315066-19-001381-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/25743/000031506620001245/0000315066-20-001245-index.htm
2020-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/25743/000083423720006840/0000834237-20-006840-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/25743/000093247119005762/0000932471-19-005762-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/25743/000110465920018756/0001104659-20-018756-index.htm
2019-10-23424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/25743/000119312519272677/0001193125-19-272677-index.htm
2019-10-23FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/25743/000119312519272683/0001193125-19-272683-index.htm
2019-10-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000119312519272703/0001193125-19-272703-index.htm
2019-10-24FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/25743/000119312519272880/0001193125-19-272880-index.htm
2019-10-25424B2Prospectus [Rule 424(b)(2)]https://www.sec.gov/Archives/edgar/data/25743/000119312519274826/0001193125-19-274826-index.htm
2019-10-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000119312519277097/0001193125-19-277097-index.htm
2020-02-24POSASRPost-effective Amendment to an automatic shelf registration statementhttps://www.sec.gov/Archives/edgar/data/25743/000119312520046336/0001193125-20-046336-index.htm
2020-02-24POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/25743/000119312520046605/0001193125-20-046605-index.htm
2018-12-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713118006726/0001387131-18-006726-index.htm
2018-12-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713118006727/0001387131-18-006727-index.htm
2018-12-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713118006797/0001387131-18-006797-index.htm
2018-12-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000138713118006811/0001387131-18-006811-index.htm
2018-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713118006855/0001387131-18-006855-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713118006984/0001387131-18-006984-index.htm
2019-01-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000138713119000111/0001387131-19-000111-index.htm
2019-01-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000138713119000127/0001387131-19-000127-index.htm
2019-02-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000138713119000777/0001387131-19-000777-index.htm
2019-02-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000138713119001384/0001387131-19-001384-index.htm
2019-02-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/25743/000138713119001471/0001387131-19-001471-index.htm
2019-03-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713119001657/0001387131-19-001657-index.htm
2019-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000138713119001840/0001387131-19-001840-index.htm
2019-04-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000138713119002554/0001387131-19-002554-index.htm
2019-04-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000138713119002719/0001387131-19-002719-index.htm
2019-04-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000138713119002928/0001387131-19-002928-index.htm
2019-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/25743/000138713119003116/0001387131-19-003116-index.htm
2019-04-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/25743/000138713119003117/0001387131-19-003117-index.htm
2019-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000138713119003362/0001387131-19-003362-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/25743/000138713119003457/0001387131-19-003457-index.htm
2019-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713119003606/0001387131-19-003606-index.htm
2019-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000138713119003624/0001387131-19-003624-index.htm
2019-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713119003731/0001387131-19-003731-index.htm
2019-06-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000138713119004260/0001387131-19-004260-index.htm
2019-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000138713119004327/0001387131-19-004327-index.htm
2019-06-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000138713119004542/0001387131-19-004542-index.htm
2019-06-21S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/25743/000138713119004545/0001387131-19-004545-index.htm
2019-06-21S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/25743/000138713119004547/0001387131-19-004547-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713119004583/0001387131-19-004583-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713119004584/0001387131-19-004584-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713119004585/0001387131-19-004585-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713119004586/0001387131-19-004586-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713119004587/0001387131-19-004587-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713119004588/0001387131-19-004588-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713119004589/0001387131-19-004589-index.htm
2019-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713119004590/0001387131-19-004590-index.htm
2019-07-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000138713119004898/0001387131-19-004898-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000138713119005793/0001387131-19-005793-index.htm
2019-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/25743/000138713119005935/0001387131-19-005935-index.htm
2019-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713119006018/0001387131-19-006018-index.htm
2019-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713119006033/0001387131-19-006033-index.htm
2019-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713119006036/0001387131-19-006036-index.htm
2019-08-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713119006150/0001387131-19-006150-index.htm
2019-08-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713119006151/0001387131-19-006151-index.htm
2019-08-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713119006191/0001387131-19-006191-index.htm
2019-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713119006246/0001387131-19-006246-index.htm
2019-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713119006289/0001387131-19-006289-index.htm
2019-08-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713119006399/0001387131-19-006399-index.htm
2019-08-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713119006602/0001387131-19-006602-index.htm
2019-08-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713119006603/0001387131-19-006603-index.htm
2019-08-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713119006604/0001387131-19-006604-index.htm
2019-08-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713119006605/0001387131-19-006605-index.htm
2019-08-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713119006606/0001387131-19-006606-index.htm
2019-08-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713119006607/0001387131-19-006607-index.htm
2019-09-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000138713119006944/0001387131-19-006944-index.htm
2019-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000138713119007118/0001387131-19-007118-index.htm
2019-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000138713119007303/0001387131-19-007303-index.htm
2019-10-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000138713119007619/0001387131-19-007619-index.htm
2019-10-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713119007988/0001387131-19-007988-index.htm
2019-10-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713119007989/0001387131-19-007989-index.htm
2019-10-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713119007990/0001387131-19-007990-index.htm
2019-10-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713119007992/0001387131-19-007992-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000138713119008376/0001387131-19-008376-index.htm
2019-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/25743/000138713119008469/0001387131-19-008469-index.htm
2019-11-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000138713119008853/0001387131-19-008853-index.htm
2019-12-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000138713119009657/0001387131-19-009657-index.htm
2019-12-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000138713119009918/0001387131-19-009918-index.htm
2020-01-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000138713120000236/0001387131-20-000236-index.htm
2020-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713120001050/0001387131-20-001050-index.htm
2020-02-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000138713120001953/0001387131-20-001953-index.htm
2020-02-2410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/25743/000138713120002086/0001387131-20-002086-index.htm
2020-03-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000138713120002411/0001387131-20-002411-index.htm
2020-03-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000138713120003130/0001387131-20-003130-index.htm
2020-03-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000138713120003271/0001387131-20-003271-index.htm
2020-03-263Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713120003282/0001387131-20-003282-index.htm
2020-03-263Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713120003284/0001387131-20-003284-index.htm
2020-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713120003589/0001387131-20-003589-index.htm
2020-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713120003590/0001387131-20-003590-index.htm
2020-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713120003591/0001387131-20-003591-index.htm
2020-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713120003592/0001387131-20-003592-index.htm
2020-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713120003593/0001387131-20-003593-index.htm
2020-04-13PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/25743/000138713120003861/0001387131-20-003861-index.htm
2020-04-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000138713120004062/0001387131-20-004062-index.htm
2020-04-22PRER14APreliminary Proxy Soliciting materialshttps://www.sec.gov/Archives/edgar/data/25743/000138713120004066/0001387131-20-004066-index.htm
2020-04-223Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713120004068/0001387131-20-004068-index.htm
2020-04-2910-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/25743/000138713120004224/0001387131-20-004224-index.htm
2020-05-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000138713120004356/0001387131-20-004356-index.htm
2020-05-04DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/25743/000138713120004409/0001387131-20-004409-index.htm
2020-05-04DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/25743/000138713120004411/0001387131-20-004411-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000138713120004451/0001387131-20-004451-index.htm
2020-05-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/25743/000138713120004479/0001387131-20-004479-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000138713120004678/0001387131-20-004678-index.htm
2020-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000138713120004921/0001387131-20-004921-index.htm
2020-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000138713120005353/0001387131-20-005353-index.htm
2020-06-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713120005478/0001387131-20-005478-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713120005521/0001387131-20-005521-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713120005523/0001387131-20-005523-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713120005525/0001387131-20-005525-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713120005580/0001387131-20-005580-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713120005591/0001387131-20-005591-index.htm
2020-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000138713120005767/0001387131-20-005767-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713120005814/0001387131-20-005814-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713120005815/0001387131-20-005815-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713120005816/0001387131-20-005816-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713120005817/0001387131-20-005817-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713120005818/0001387131-20-005818-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713120005819/0001387131-20-005819-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713120005820/0001387131-20-005820-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713120005821/0001387131-20-005821-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713120005822/0001387131-20-005822-index.htm
2020-06-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000138713120005881/0001387131-20-005881-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000138713120007080/0001387131-20-007080-index.htm
2020-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/25743/000138713120007144/0001387131-20-007144-index.htm
2020-08-07S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/25743/000138713120007210/0001387131-20-007210-index.htm
2020-08-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713120007223/0001387131-20-007223-index.htm
2020-08-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713120007225/0001387131-20-007225-index.htm
2020-08-074/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713120007227/0001387131-20-007227-index.htm
2020-08-14DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/25743/000138713120007573/0001387131-20-007573-index.htm
2020-09-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/25743/000138713120008293/0001387131-20-008293-index.htm
2019-01-29SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/25743/000139077719000020/0001390777-19-000020-index.htm
2019-09-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/25743/000139077719000099/0001390777-19-000099-index.htm
2019-12-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/25743/000139077719000118/0001390777-19-000118-index.htm
2019-01-28SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/25743/000156761919001768/0001567619-19-001768-index.htm
2020-05-05EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/25743/999999999520001030/9999999995-20-001030-index.htm
2018-12-12CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/25743/999999999718009474/9999999997-18-009474-index.htm
2019-04-10CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/25743/999999999719002658/9999999997-19-002658-index.htm
2020-02-04SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/25743/999999999720000456/9999999997-20-000456-index.htm
2020-03-05SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/25743/999999999720001150/9999999997-20-001150-index.htm

TherapeuticsMD, Inc (TXMD) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of TherapeuticsMD, Inc (TXMD). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1122%
Institutional Ownership: 5405%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-02-03Mitchell KrassanChief Strategy OfficerSell300,000.002.26676,920.000.00https://www.sec.gov/Archives/edgar/data/25743/000138713120001050/0001387131-20-001050-index.htm
2020-02-03Mitchell KrassanChief Strategy OfficerBuy105,703.000.1919,808.74105,703.00https://www.sec.gov/Archives/edgar/data/25743/000138713120001050/0001387131-20-001050-index.htm
2020-06-09Cooper C. CollinsDirectorBuy47,500.001.4568,875.00140,000.00https://www.sec.gov/Archives/edgar/data/25743/000138713120005591/0001387131-20-005591-index.htm
2018-12-17John C.K. IV MilliganPresident/SecretarySell129,000.003.75483,750.001,472,419.00https://www.sec.gov/Archives/edgar/data/25743/000138713118006855/0001387131-18-006855-index.htm
2018-12-18John C.K. IV MilliganPresident/SecretarySell129,127.003.64469,634.901,472,419.00https://www.sec.gov/Archives/edgar/data/25743/000138713118006855/0001387131-18-006855-index.htm
2019-10-25John C.K. IV MilliganPresident/SecretaryBuy72,000.002.75198,000.001,544,419.00https://www.sec.gov/Archives/edgar/data/25743/000138713119007990/0001387131-19-007990-index.htm
2018-12-17John C.K. IV MilliganPresident/SecretaryBuy129,000.000.1013,132.201,601,419.00https://www.sec.gov/Archives/edgar/data/25743/000138713118006855/0001387131-18-006855-index.htm
2018-12-18John C.K. IV MilliganPresident/SecretaryBuy129,127.000.1013,145.131,601,546.00https://www.sec.gov/Archives/edgar/data/25743/000138713118006855/0001387131-18-006855-index.htm
2019-08-09Robert G FinizioCEOBuy52,405.002.96155,118.8018,218,964.00https://www.sec.gov/Archives/edgar/data/25743/000138713119006018/0001387131-19-006018-index.htm
2019-08-20Robert G FinizioCEOBuy35,000.002.7495,900.0018,253,964.00https://www.sec.gov/Archives/edgar/data/25743/000138713119006289/0001387131-19-006289-index.htm
2019-10-25Robert G FinizioCEOBuy72,000.002.75198,000.0018,325,964.00https://www.sec.gov/Archives/edgar/data/25743/000138713119007988/0001387131-19-007988-index.htm
2020-06-05Robert G FinizioCEOBuy10,000.001.1611,600.0018,335,964.00https://www.sec.gov/Archives/edgar/data/25743/000138713120005521/0001387131-20-005521-index.htm
2020-06-05Robert G FinizioCEOBuy20,000.001.1523,000.0018,355,964.00https://www.sec.gov/Archives/edgar/data/25743/000138713120005521/0001387131-20-005521-index.htm
2018-12-06Robert G FinizioCEOSell92,000.004.57420,624.0018,366,559.00https://www.sec.gov/Archives/edgar/data/25743/000138713118006727/0001387131-18-006727-index.htm
2018-12-07Robert G FinizioCEOSell92,000.004.60423,568.0018,366,559.00https://www.sec.gov/Archives/edgar/data/25743/000138713118006727/0001387131-18-006727-index.htm
2018-12-19Robert G FinizioCEOSell92,000.003.70340,216.0018,366,559.00https://www.sec.gov/Archives/edgar/data/25743/000138713118006984/0001387131-18-006984-index.htm
2018-12-20Robert G FinizioCEOSell92,910.003.63336,891.6618,366,559.00https://www.sec.gov/Archives/edgar/data/25743/000138713118006984/0001387131-18-006984-index.htm
2020-06-09Robert G FinizioCEOBuy21,000.001.4129,610.0018,376,964.00https://www.sec.gov/Archives/edgar/data/25743/000138713120005580/0001387131-20-005580-index.htm
2020-06-09Robert G FinizioCEOBuy25,000.001.4736,750.0018,401,964.00https://www.sec.gov/Archives/edgar/data/25743/000138713120005580/0001387131-20-005580-index.htm
2018-12-06Robert G FinizioCEOBuy92,000.000.109,365.6018,458,559.00https://www.sec.gov/Archives/edgar/data/25743/000138713118006727/0001387131-18-006727-index.htm
2018-12-07Robert G FinizioCEOBuy92,000.000.109,365.6018,458,559.00https://www.sec.gov/Archives/edgar/data/25743/000138713118006727/0001387131-18-006727-index.htm
2018-12-19Robert G FinizioCEOBuy92,000.000.109,365.6018,458,559.00https://www.sec.gov/Archives/edgar/data/25743/000138713118006984/0001387131-18-006984-index.htm
2018-12-20Robert G FinizioCEOBuy92,910.000.109,458.2418,459,469.00https://www.sec.gov/Archives/edgar/data/25743/000138713118006984/0001387131-18-006984-index.htm
2020-02-03Mitchell KrassanChief Strategy OfficerBuy194,297.000.2039,578.30300,000.00https://www.sec.gov/Archives/edgar/data/25743/000138713120001050/0001387131-20-001050-index.htm
2019-08-12Jane F BarlowDirectorBuy3,144.003.189,997.923,144.00https://www.sec.gov/Archives/edgar/data/25743/000138713119006151/0001387131-19-006151-index.htm
2019-08-12John C.K. IV MilliganPresident/SecretaryBuy15,000.003.1647,400.003,572,373.00https://www.sec.gov/Archives/edgar/data/25743/000138713119006150/0001387131-19-006150-index.htm
2019-08-16John C.K. IV MilliganPresident/SecretaryBuy10,000.002.9329,300.003,582,373.00https://www.sec.gov/Archives/edgar/data/25743/000138713119006246/0001387131-19-006246-index.htm
2018-12-06Daniel A CartwrightCFOBuy40,000.000.3815,200.0040,000.00https://www.sec.gov/Archives/edgar/data/25743/000138713118006726/0001387131-18-006726-index.htm
2018-12-06Daniel A CartwrightCFOSell40,000.004.57182,800.0040,000.00https://www.sec.gov/Archives/edgar/data/25743/000138713118006726/0001387131-18-006726-index.htm
2019-02-27JULES A. MUSINGDirectorSell17,400.005.80100,920.005,000.00https://www.sec.gov/Archives/edgar/data/25743/000138713119001657/0001387131-19-001657-index.htm
2020-06-04PAUL BISARODirectorBuy50,000.001.1457,000.0050,000.00https://www.sec.gov/Archives/edgar/data/25743/000138713120005523/0001387131-20-005523-index.htm
2019-08-09Brian BernickDirectorBuy10,000.002.8728,700.0062,000.00https://www.sec.gov/Archives/edgar/data/25743/000138713119006033/0001387131-19-006033-index.htm
2018-12-12Brian BernickDirectorSell91,400.004.18381,960.606,557,371.00https://www.sec.gov/Archives/edgar/data/25743/000138713118006797/0001387131-18-006797-index.htm
2018-12-13Brian BernickDirectorSell91,910.004.12378,577.296,557,371.00https://www.sec.gov/Archives/edgar/data/25743/000138713118006797/0001387131-18-006797-index.htm
2019-05-13Cooper C. CollinsDirectorBuy30,000.003.3399,870.0066,000.00https://www.sec.gov/Archives/edgar/data/25743/000138713119003731/0001387131-19-003731-index.htm
2018-12-12Brian BernickDirectorBuy91,400.000.109,304.526,648,771.00https://www.sec.gov/Archives/edgar/data/25743/000138713118006797/0001387131-18-006797-index.htm
2018-12-13Brian BernickDirectorBuy91,910.000.109,356.446,649,281.00https://www.sec.gov/Archives/edgar/data/25743/000138713118006797/0001387131-18-006797-index.htm
2019-05-13Tommy G ThompsonDirectorBuy2,400.003.348,016.00685,900.00https://www.sec.gov/Archives/edgar/data/25743/000138713119003606/0001387131-19-003606-index.htm
2019-08-09Tommy G ThompsonDirectorBuy5,000.003.0415,200.00690,900.00https://www.sec.gov/Archives/edgar/data/25743/000138713119006036/0001387131-19-006036-index.htm
2020-06-04Tommy G ThompsonDirectorBuy8,700.001.139,831.00699,600.00https://www.sec.gov/Archives/edgar/data/25743/000138713120005525/0001387131-20-005525-index.htm
2019-08-14Angus C. RussellDirectorBuy25,000.002.7669,000.0073,500.00https://www.sec.gov/Archives/edgar/data/25743/000138713119006191/0001387131-19-006191-index.htm
2019-08-15Angus C. RussellDirectorBuy10,000.002.9929,900.0083,500.00https://www.sec.gov/Archives/edgar/data/25743/000138713119006191/0001387131-19-006191-index.htm
2020-06-08Cooper C. CollinsDirectorBuy26,500.001.4538,425.0092,500.00https://www.sec.gov/Archives/edgar/data/25743/000138713120005591/0001387131-20-005591-index.htm
2019-08-23Angus C. RussellDirectorBuy10,000.002.7727,700.0093,500.00https://www.sec.gov/Archives/edgar/data/25743/000138713119006399/0001387131-19-006399-index.htm
2019-10-25Brian BernickDirectorBuy36,000.002.7599,000.0098,000.00https://www.sec.gov/Archives/edgar/data/25743/000138713119007989/0001387131-19-007989-index.htm